secwatch.observer — SEC 8-K summary
======================================

Issuer:     Novo Integrated Sciences, Inc. (—)
CIK:        0001138978
Form:       8-K
Filed at:   2024-10-31T23:59:59+00:00
Accession:  0001493152-24-043222
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Novo Integrated Sciences President Robert Oliva resigns effective Oct 25, 2024
------------------------------------------------------------------------------

- Robert Oliva resigned as President of Novo Integrated Sciences, effective October 25, 2024.
- Resignation was not due to any disagreement with the company on operations, policies, or practices.
- No successor named; CEO Robert Mattacchione remains in place.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1138978/000149315224043222/0001493152-24-043222-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1138978/000149315224043222/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-043222

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer